Patents Assigned to BCM Technologies
  • Patent number: 4894373
    Abstract: Disclosed is a method for treating menopausal symptoms and treating and preventing osteoporosis, wherein a true antiestrogen is administered and estrogen is not. This treatment is effective for female osteoporosis and can also be used to treat male osteoporosis. Examples of true antiestrogens are clomiphene, and its isomers, citrates and derivatives, as well as several other compounds which appear in the specification.
    Type: Grant
    Filed: January 12, 1988
    Date of Patent: January 16, 1990
    Assignee: BCM Technologies, Inc.
    Inventor: Ronald L. Young
  • Patent number: 4729999
    Abstract: The invention involves a method for treating symptoms secondary to estrogen deficiency without using estrogen. Weakly estrogenic antiestrogens are administered to estrogen deficient women in the absence of estrogen administration. Maximum estrogenic activity is therby obtained and the harmful side effects of estrogen therapy are avoided.
    Type: Grant
    Filed: October 12, 1984
    Date of Patent: March 8, 1988
    Assignee: BCM Technologies
    Inventor: Ronald L. Young